Detecting millions of consistently unidentified spectra in vast tracts of proteomics data is possible with a new algorithm developed at EMBL-EBI
A new algorithm clusters the millions of peptide mass spectra in the PRIDE Archive public database, making it easier to detect millions of consistently unidentified spectra across different datasets. Published in Nature Methods, the new tool is an important step towards fully exploiting data produced in discovery proteomics experiments.
On average, almost three quarters of spectra measured in discovery proteomics experiments remain unidentified, regardless of the quality of the experiment, as they cannot be interpreted by standard sequence-based search engines.
Alternative approaches to improve the rate of identification exist, but are fraught with disadvantages including ambiguous results. In today's study, researchers working on the PRIDE Archive public repository of proteomics data present a large-scale 'spectrum clustering' solution that takes advantage of the growing number of mass spectrometry (MS) datasets to systematically study millions of unidentified spectra.
"MS experiments produce huge amounts of data, but identifying meaningful sequences that could be assigned to specific biological functions can be troublesome," says Johannes Griss, formerly at EMBL-EBI in the UK and now at the Medical University of Vienna, Austria.
"Discovery proteomics is a mature technology, and it's crucial that we are able to exploit the data efficiently."
One of the challenges with these technologies is that a large proportion of the data generated can't be interpreted, as they correspond to peptides that have not yet been observed and are not available in databases. Such spectra could correspond to peptide variants derived from individual generic variation, or to peptides containing post-translational modifications, which are essential for the biological functions of proteins.
"What we have now is an algorithm that shows us patterns, or groups of spectra, that we've consistently missed, and helps us figure out which ones are good enough to pursue," adds Johannes. "It's a valuable tool that helps us unpick what's going on in proteomics, so we can better understand basic biological processes."
The team used the approach to recognise 9 million consistently unidentified spectra, which can make post-translational modifications and peptides containing sequence variants more discoverable. They identified three distinct sets of spectra: those that have been incorrectly identified, those that are not of high enough quality to identify properly, and those that are truly unidentified. They also combined their new approach with other methods to identify roughly 20% of the originally unidentified spectra in the public archive.
"Discovery proteomics is a mature technology, and it's crucial that we are able to exploit the data efficiently - but creating a sensible subset of spectra to start an in-depth analysis of unidentified spectra has been very challenging," says Juan Antonio Vizcaíno, who leads the Proteomics team at EMBL-EBI. "We developed a comparatively lightweight computational approach that makes it much easier to detect sequences that have been incorrectly identified, or consistently observed but not identified. These ready-to-use collections of commonly unidentified spectra are a resource for the community, so that we can all pool our efforts to find lasting solutions for proteomics research."
The new algorithm will be used to improve quality control in the PRIDE Archive. The complete spectrum clustering results are available through the PRIDE Cluster resource, which aims to simplify further investigation into unidentified spectra.
Source article: Griss J., et al. (2016). Recognizing millions of consistently unidentified spectra across hundreds of shotgun proteomics datasets. Nature Methods (in press). DOI: 10.1038/nmeth.3902
Mary Todd Bergman | EurekAlert!
North and South Cooperation to Combat Tuberculosis
22.03.2018 | Universität Zürich
Researchers Discover New Anti-Cancer Protein
22.03.2018 | Universität Basel
An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.
The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...
In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.
Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...
Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.
They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...
A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.
In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...
19.03.2018 | Event News
16.03.2018 | Event News
13.03.2018 | Event News
22.03.2018 | Trade Fair News
22.03.2018 | Earth Sciences
22.03.2018 | Earth Sciences